Combined prostate diffusion tensor imaging and dynamic contrast enhanced MRI at 3T - quantitative correlation with biopsy

Magnetic Resonance Imaging

Volumn 28, Issue 5, 2010, Pages 621-628

  Kozlowski, Piotr ^a,b   Chang, Silvia D ^a,b   Meng, Ran ^b   Mädler, Burkhard ^b,c   Bell, Robert ^a   Jones, Edward C ^b   Goldenberg, S Larry ^a,b  

^a VANCOUVER PROSTATE CENTRE   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c PHILIPS HEALTHCARE   (United States)

Author keywords

3T; Biopsy; Diffusion tensor imaging; Dynamic contrast enhanced MRI; Logistic regression analysis; Prostate cancer

Indexed keywords

GADOLINIUM PENTETATE; CONTRAST MEDIUM;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFUSION TENSOR IMAGING; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; NONPARAMETRIC TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TRANSRECTAL ULTRASONOGRAPHY; WILCOXON SIGNED RANKS TEST; BIOPSY; COMPARATIVE STUDY; DIAGNOSTIC USE; DIFFUSION WEIGHTED IMAGING; ECHO PLANAR IMAGING; EVALUATION STUDY; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROSTATE TUMOR; REPRODUCIBILITY; STATISTICS;

ADULT; AGED; BIOPSY; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; ECHO-PLANAR IMAGING; GADOLINIUM DTPA; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC;

EID: 77952954909     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2010.03.011     Document Type: Article

References (35)

1. Sinha S., Sinha U. In vivo diffusion tensor imaging of the human prostate. Magn Reson Med 2004, 52:530-537.
2. Gibbs P., Pickles M.D., Sreenivas M., Knowles A., Turnbull L.W. Diffusion tensor imaging of the normal and pathologic prostate at 3T. Proceedings of the 13th Annual Meeting of ISMRM, Miami 2005, 1940.
3. Engelbrecht M.R., Huisman H.J., Laheij R.J., Jager G.J., van Leenders G.J., Hulsbergen-van de Kaa C.A., et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 2003, 229:248-254.
4. Buckley D.L., Roberts C., Parker G.J., Logue J.P., Hutchinson C.E. Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging-initial experience. Radiology 2004, 233:709-715.
5. Kurhanewicz J., Vigneron D.B., Hricak H., Narayan P., Carroll P., Nelson S.J. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. Radiology 1996, 198:795-805.
6. Parivar F., Hricak H., Shinohara K., Kurhanewicz J., Vigneron D.B., Nelson S.J., et al. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy. Urology 1996, 48:594-599.
7. Reinsberg S.A., Payne G.S., Riches S.F., Ashley S., Brewster J.M., Morgan V.A., et al. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection. AJR Am J Roentgenol 2007, 188:91-98.
8. Kajihara H., Hayashida Y., Murakami R., Katahira K., Nishimura R., Hamada Y., et al. Usefulness of diffusion-weighted imaging in the localization of prostate cancer. Int J Radiat Oncol Biol Phys 2008, 74:399-403.
9. Villeirs G.M., Oosterlinck W., Vanherreweghe E., De Meerleer G.O. A qualitative approach to combined magnetic resonance imaging and spectroscopy in the diagnosis of prostate cancer. Eur J Radiol 2010, 73:352-356.
10. Haider M.A., van der Kwast T.H., Tanguay J., Evans A.J., Hashmi A.T., Lockwood G., et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 2007, 189:323-328.
11. Cheikh A.B., Girouin N., Colombel M., Maréchal J.M., Gelet A., Bissery A., et al. Evaluation of T2-weighted and dynamic contrast-enhanced MRI in localizing prostate cancer before repeat biopsy. Eur Radiol 2009, 19:770-778.
12. Chen M., Dang H.D., Wang J.Y., Zhou C., Li S.Y., Wang W.C., et al. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined. Acta Radiol 2008, 49:602-610.
13. Langer D.L., van der Kwast T.H., Evans A.J., Trachtenberg J., Wilson B.C., Haider M.A. Prostate cancer detection: multi-parametric MRI with diffusion weighted imaging and dynamic contrast enhanced MRI. Proceedings of the 17th Annual Meeting of ISMR, Honolulu 2009, 782.
14. Kozlowski P., Chang S.D., Jones E.C., Berean K.W., Chen H., Goldenberg S.L. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis-correlation with biopsy and histopathology. J Magn Reson Imaging 2006, 24:108-113.
15. Parker G.J., Suckling J., Tanner S.F., Padhani A.R., Revell P.B., Husband J.E., et al. Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics. J Magn Reson Imaging 1997, 7:564-574.
16. Parker G.J., Roberts C., Macdonald A., Buonaccorsi G.A., Cheung S., Buckley D.L., et al. Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med 2006, 56:993-1000.
17. Meng R., Maedler B., Chang S.D., Jones E.C., Goldenberg S.L., Kozlowski P. 3T DCE MRI in prostate cancer - comparison between population average and patient specific Arterial Input Function. Proceedings of the 17th Annual Meeting of ISMR, Honolulu 2009, 2240.
18. Tofts P.S., Brix G., Buckley D.L., Evelhoch J.L., Henderson E., Knopp M.V., et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999, 10:223-232.
19. Hosseinzadeh K., Schwarz S.D. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging 2004, 20:654-661.
20. Padhani A.R., Gapinski C.J., Macvicar D.A., Parker G.J., Suckling J., Revell P.B., et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 2000, 55:99-109.
21. Mould R.F. Sensitivity and specificity. Introductory medical statistics 1998, 232-233. Institute of Physics Publishing, Bristol and Philadelphia. 3rd ed.
22. Newcombe R.G. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 2008, 17:857-872.
23. Berkson J. Application of the logistic function to bio-assay. J Am Stat Assoc 1944, 39:357-365.
24. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristics curves: a nonparametric approach. Biometrics 1988, 44:837-845.
25. Lyng H., Haraldseth O., Rofstad E.K. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 2000, 43:828-836.
26. Noworolski S.M., Vigneron D.B., Chen A.P., Kurhanewicz J. Dynamic contrast-enhanced MRI and MR diffusion imaging to distinguish between glandular and stromal prostatic tissues. Magn Reson Imaging 2008, 26:1071-1080.
27. Yoshizako T., Wada A., Hayashi T., Uchida K., Sumura M., Uchida N., et al. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer. Acta Radiol 2008, 49:1207-1213.
28. Gibbs P., Pickles M.D., Turnbull L.W. Diffusion imaging of the prostate at 3.0 Tesla. Invest Radiol 2006, 41:185-188.
29. Gürses B., Kabakci N., Kovanlikaya A., Firat Z., Bayram A., Ulug A.M., et al. Diffusion tensor imaging of the normal prostate at 3 Tesla. Eur Radiol 2008, 18:716-721.
30. Manenti G., Carlani M., Mancino S., Colangelo V., Di Roma M., Squillaci E., et al. Diffusion tensor magnetic resonance imaging of prostate cancer. Invest Radiol 2007, 42:412-419.
31. Xu J., Humphrey P.A., Kibel A.S., Snyder A.Z., Narra V.R., Ackerman J.J., et al. Magnetic resonance diffusion characteristics of histologically defined prostate cancer in humans. Magn Reson Med 2009, 61:842-850.
32. Takayama Y., Kishimoto R., Hanaoka S., Nonaka H., Kandatsu S., Tsuji H., et al. ADC value and diffusion tensor imaging of prostate cancer: changes in carbon-ion radiotherapy. J Magn Reson Imaging 2008, 27:1331-1335.
33. Gibbs P., Pickles M.D., Turnbull L.W. Repeatability of echo-planar-based diffusion measurements of the human prostate at 3 T. Magn Reson Imaging 2007, 25:1423-1429.
34. Gibbs P., Liney G.P., Pickles M.D., Zelhof B., Rodrigues G., Turnbull L.W. Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla. Invest Radiol 2009, 44:572-576.
35. Noworolski S.M., Chen A.P., Vigneron D.B., Kurhanewicz J. Assessment of prostatic ductal volume using combined Dynamic Contrast-Enhanced MRI and Diffusion MRI. Proceedings of the 11th Annual Meeting of ISMRM, Toronto 2003, 1464.